Automatic classification of benign and malignant kidney masses using radiomics. A retrospective study on KiTS19 dataset

Beyond Data Capture: Choosing an eClinical Ecosystem That Scales With Your Trial

Why Endpoint Adjudication Remains Critical to Trial Credibility and Regulatory Confidence

Why Central Imaging Has Become a Strategic Asset in Clinical Trial